Tenon Medical, Inc. (TNON)
NASDAQ: TNON · Real-Time Price · USD
1.350
-0.050 (-3.57%)
At close: Aug 7, 2025, 4:00 PM
1.390
+0.040 (2.96%)
Pre-market: Aug 8, 2025, 7:55 AM EDT

Tenon Medical Stock Forecast

TNON's stock price has decreased by -70.34% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts that cover Tenon Medical stock have a consensus rating of "Strong Buy" and an average price target of $11.67, which forecasts a 764.44% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $24.

Price Target: $11.67 (+764.44%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$3.00$11.67$8.00$24
Change+122.22%+764.44%+492.59%+1677.8%
* Price targets were last updated on Apr 9, 2025.

Analyst Ratings

The average analyst rating for Tenon Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy112222
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total223333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Alliance Global Partners
Alliance Global Partners
Strong Buy
Initiates
$3
Strong BuyInitiates$3+122.22%Apr 9, 2025
Maxim Group
Maxim Group
Strong Buy
Maintains
$22$8
Strong BuyMaintains$22$8+492.59%Nov 15, 2024
Benchmark
Benchmark
Buy
Reiterates
$24
BuyReiterates$24+1,677.78%Aug 14, 2024
Benchmark
Benchmark
Buy
Maintains
$40$24
BuyMaintains$40$24+1,677.78%Apr 15, 2024
Benchmark
Benchmark
Strong Buy
Reiterates
$480
Strong BuyReiterates$480+35,455.56%Mar 10, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
4.56M
from 3.28M
Increased by 39.03%
Revenue Next Year
7.57M
from 4.56M
Increased by 66.24%
EPS This Year
-2.00
from -11.26
EPS Next Year
-0.97
from -2.00
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
43.82K160.00K691.00K2.93M3.28M4.56M7.57M11.90M
Revenue Growth
-18.31%265.13%331.88%323.73%11.92%39.03%66.24%57.14%
EPS
-56.40-624.38-187.30-68.64-11.26-2.00-0.97-0.66
EPS Growth
--------
Forward PE
--------
No. Analysts
-----443
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High5.1M7.9M12.3M
Avg4.6M7.6M11.9M
Low4.0M7.2M11.4M

Revenue Growth

Revenue Growth20252026202720282029
High
56.6%
73.3%
61.8%
Avg
39.0%
66.2%
57.1%
Low
21.0%
57.7%
51.0%

EPS Forecast

EPS20252026202720282029
High-2.05-0.89-0.68
Avg-2.00-0.97-0.66
Low-1.94-1.03-0.64

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.